{"name":"Cristália Produtos Químicos Farmacêuticos Ltda.","slug":"crist-lia-produtos-qu-micos-farmac-uticos-ltda","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Fentanyl Transdermal","genericName":"Fentanyl Transdermal","slug":"fentanyl-transdermal","indication":"Pain","status":"marketed"},{"name":"bupivacaine S50:R50 plus 8% glucose","genericName":"bupivacaine S50:R50 plus 8% glucose","slug":"bupivacaine-s50-r50-plus-8-glucose","indication":"Spinal anesthesia for surgical procedures","status":"phase_3"},{"name":"bupivacaine S75:R25 plus 8% glucose","genericName":"bupivacaine S75:R25 plus 8% glucose","slug":"bupivacaine-s75-r25-plus-8-glucose","indication":"Local anesthesia for surgical procedures","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"cardiovascular","drugs":[{"name":"Nitroprusside, Sodium","genericName":"Nitroprusside, Sodium","slug":"nitroprusside-sodium","indication":"Acute hypertensive crisis","status":"marketed"},{"name":"Sodium Enoxaparin clexane","genericName":"Sodium Enoxaparin clexane","slug":"sodium-enoxaparin-clexane","indication":"Prophylaxis of venous thromboembolism in surgical patients","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Kollagenase","genericName":"Kollagenase","slug":"kollagenase","indication":"Other","status":"discontinued"}]}],"pipeline":[{"name":"Fentanyl Transdermal","genericName":"Fentanyl Transdermal","slug":"fentanyl-transdermal","phase":"marketed","mechanism":"Fentanyl acts as an opioid agonist, primarily interacting with mu-opioid receptors in the brain, spinal cord, and other tissues.","indications":[],"catalyst":""},{"name":"Kollagenase","genericName":"Kollagenase","slug":"kollagenase","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Nitroprusside, Sodium","genericName":"Nitroprusside, Sodium","slug":"nitroprusside-sodium","phase":"marketed","mechanism":"Sodium nitroprusside releases nitric oxide, which activates guanylate cyclase to increase cGMP levels, causing vasodilation of both arteries and veins.","indications":["Acute hypertensive crisis","Cardiogenic shock","Controlled hypotension during anesthesia"],"catalyst":""},{"name":"Sodium Enoxaparin clexane","genericName":"Sodium Enoxaparin clexane","slug":"sodium-enoxaparin-clexane","phase":"phase_3","mechanism":"Enoxaparin is a low-molecular-weight heparin that inhibits blood clotting by enhancing the activity of antithrombin III against factors Xa and IIa.","indications":["Prophylaxis of venous thromboembolism in surgical patients","Treatment of acute deep vein thrombosis","Treatment of acute pulmonary embolism","Prophylaxis in medically ill patients at risk of thromboembolism","Acute coronary syndrome"],"catalyst":""},{"name":"bupivacaine S50:R50 plus 8% glucose","genericName":"bupivacaine S50:R50 plus 8% glucose","slug":"bupivacaine-s50-r50-plus-8-glucose","phase":"phase_3","mechanism":"Bupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials.","indications":["Spinal anesthesia for surgical procedures","Regional anesthesia for pain management"],"catalyst":""},{"name":"bupivacaine S75:R25 plus 8% glucose","genericName":"bupivacaine S75:R25 plus 8% glucose","slug":"bupivacaine-s75-r25-plus-8-glucose","phase":"phase_3","mechanism":"Bupivacaine is a local anesthetic that blocks sodium channels to prevent nerve impulses.","indications":["Local anesthesia for surgical procedures","Pain management for chronic conditions"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2024-09-27","type":"pipeline","source":"Valor International","summary":"Leadership struggle at Cristália Pharmaceuticals: founder reclaims role amid disputes - Valor International","headline":"Leadership struggle at Cristália Pharmaceuticals: founder reclaims role amid disputes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxQOGJ5TzJDa2Z0bFhSbW9xT3dJdVJVdmlYUHJmaHpGX2RzUkMwY29ObDFEY2YwYXBhSW53TTFDWmdSZGJvSWNLdUptdWlSbkdyd1F4Sk90Nkdaek1vWmhnZTZQN1I4OWRPcHlGaWhuTFhJUHVDQ0plVFFCNGs4S0lQdWZHTGFJVUdqRG5sRmVla1hNZ1d1NGh3eUM5LVNkQUFZYlpEWGlja3JrTDRxOUdCRldNM3J2VTMwMGM2M3Jzckt2aXNqaUZNYlFhTzVrUFVUS2UweUM1VkdrTkotTUdxQWRxV1J5WFVMN2xza3dYOVNIUTBDcURLNzBBODB2NmlqWTlQVkd6SkpJOWI0aHdTdG9FZ2pHcFJrX3NWZXJfc0pxVmhYT3c?oc=5","date":"2024-01-26","type":"pipeline","source":"BioSpace","summary":"Formosa Pharmaceuticals Announces Licensing Agreement with Cristália, for the Commercialization of APP13007 for the Treatment of Inflammation and Pain Following Ocular Surgery - BioSpace","headline":"Formosa Pharmaceuticals Announces Licensing Agreement with Cristália, for the Commercialization of APP13007 for the Trea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE5nQ0FwcmlzZUw4Q3ZMb0lVSlF0TUM1b0hpaFNjbjhqYl9mVGRVRjdBRXhSNmE3RU14eVVlRW1UdnM2d04zbDdKcDNkV2FYa0tOck10bFI0c0ZVTzVhRU5maXZiY3FVMi1pZ2syQUFkc3ZEdlVzaVFiWlZjWVJzUQ?oc=5","date":"2022-01-14","type":"regulatory","source":"Generics and Biosimilars Initiative","summary":"Biosimilars approved in Brazil - Generics and Biosimilars Initiative","headline":"Biosimilars approved in Brazil","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNakZJcDlRS3ppcDRKWDBiREo0UTFLbEE0ZmhVZVhVbFI5c1A2VnFQa1NOVXRQMGFyUFllUE9GR045OElSOEl2NzVGOUFnUDZCMUw1Y1RlWDZjck9Bek5xQVh3SDktTDE0UlpPbEd0UmxBVTctcjk4ZWZmSjdYdzhhWnVkLVloUdIBiwFBVV95cUxNcXNDdzFlckZydzFCM0xNcmRvcl93VUR6RENiR09rdW9QR1NwRkpXR0pzRUxmNmVnRDRoZzcxYmFBUGQ5bzVZOWNwWkZBTG5Eam5ZOUVfQnJJbTN6endKX2xlYUMwOFh0RUlyOXc2WVVXZDBDT0E1TzU1UWZTMTFoaldHczZ4cEJITGpB?oc=5","date":"2013-09-10","type":"patent","source":"The National Law Review","summary":"Understanding Biologics and Biosimilars in Brazil - The National Law Review","headline":"Understanding Biologics and Biosimilars in Brazil","sentiment":"neutral"}],"patents":[],"drugCount":6,"phaseCounts":{"marketed":2,"discontinued":1,"phase_3":3},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}